




Searching News Database: BioTherapeutics
HSMN NewsFeed - 10 Feb 2022
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
HSMN NewsFeed - 30 Dec 2021
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
HSMN NewsFeed - 27 Jul 2021
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
HSMN NewsFeed - 29 Sep 2020
Prometheus Biosciences Appoints Olivier Laurent, Ph.D. as Chief Technology Officer
Prometheus Biosciences Appoints Olivier Laurent, Ph.D. as Chief Technology Officer
HSMN NewsFeed - 10 Aug 2020
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
HSMN NewsFeed - 3 Jul 2020
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
HSMN NewsFeed - 13 Apr 2020
Stealth Biotherapeutics Announces $20 Million Financing to Advance Development of Elamipretide and Pipeline
Stealth Biotherapeutics Announces $20 Million Financing to Advance Development of Elamipretide and Pipeline
HSMN NewsFeed - 16 Jan 2020
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
HSMN NewsFeed - 19 Dec 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
HSMN NewsFeed - 16 Sep 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
HSMN NewsFeed - 23 Apr 2019
Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors
Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors
HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
HSMN NewsFeed - 6 Dec 2018
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors
HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
HSMN NewsFeed - 23 Aug 2018
IDELVION(R) 3500 IU Vials Now Available to Provide Convenience to Patients
IDELVION(R) 3500 IU Vials Now Available to Provide Convenience to Patients
HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
HSMN NewsFeed - 15 Feb 2018
GT Biopharma Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
GT Biopharma Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
HSMN NewsFeed - 27 Dec 2017
Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission
Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission
HSMN NewsFeed - 27 Nov 2017
Stealth BioTherapeutics Granted Fast Track Designation for the Treatment of Barth Syndrome
Stealth BioTherapeutics Granted Fast Track Designation for the Treatment of Barth Syndrome
HSMN NewsFeed - 3 Nov 2017
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
HSMN NewsFeed - 12 Sep 2017
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
HSMN NewsFeed - 21 Jul 2017
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
HSMN NewsFeed - 3 Apr 2017
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
HSMN NewsFeed - 18 Aug 2016
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
HSMN NewsFeed - 11 May 2016
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
HSMN NewsFeed - 9 May 2016
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
HSMN NewsFeed - 5 May 2016
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
HSMN NewsFeed - 25 Jun 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
HSMN NewsFeed - 21 May 2015
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
HSMN NewsFeed - 22 Dec 2014
ZOLL Announces Definitive Agreement to Acquire Advanced Circulatory Systems, Inc.
ZOLL Announces Definitive Agreement to Acquire Advanced Circulatory Systems, Inc.
HSMN NewsFeed - 24 Nov 2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
HSMN NewsFeed - 23 Sep 2014
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
HSMN NewsFeed - 9 Jul 2014
Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors
Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors
HSMN NewsFeed - 18 Jun 2014
Oxford BioTherapeutics Appoints Dr Keith E Wilson as Chief Scientific Officer
Oxford BioTherapeutics Appoints Dr Keith E Wilson as Chief Scientific Officer
HSMN NewsFeed - 12 May 2014
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs
HSMN NewsFeed - 28 Apr 2014
Coherus Biosciences Appoints Michael A. Fleming as Senior Vice President, Commercial Strategy
Coherus Biosciences Appoints Michael A. Fleming as Senior Vice President, Commercial Strategy
HSMN NewsFeed - 16 Apr 2014
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
HSMN NewsFeed - 24 Mar 2014
BEAT BioTherapeutics Appoints Dr. Sam L. Teichman as Chief Medical Officer
BEAT BioTherapeutics Appoints Dr. Sam L. Teichman as Chief Medical Officer
HSMN NewsFeed - 17 Mar 2014
BioCardia(R) Receives CE Mark for Morph AccessPro(TM) Steerable Introducer
BioCardia(R) Receives CE Mark for Morph AccessPro(TM) Steerable Introducer
HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
HSMN NewsFeed - 31 Dec 2013
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
HSMN NewsFeed - 10 Jul 2013
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
HSMN NewsFeed - 5 Jun 2013
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
HSMN NewsFeed - 29 Apr 2013
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
HSMN NewsFeed - 7 Feb 2013
Fully Automatic AED Plus from ZOLL Granted 510(k) Clearance by U.S. Food and Drug Administration
Fully Automatic AED Plus from ZOLL Granted 510(k) Clearance by U.S. Food and Drug Administration
HSMN NewsFeed - 28 Nov 2012
Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
HSMN NewsFeed - 17 Jul 2012
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
HSMN NewsFeed - 25 May 2012
Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
HSMN NewsFeed - 2 May 2012
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Northwest Biotherapeutics Announces Change and Expansion of Management Team
HSMN NewsFeed - 11 Apr 2011
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
HSMN NewsFeed - 25 Feb 2011
FDA Issues Complete Response Letter for Taliglucerase Alfa New Drug Application
FDA Issues Complete Response Letter for Taliglucerase Alfa New Drug Application
HSMN NewsFeed - 27 Jan 2011
CSL Behring Receives National Marketing Authorization of Berinert(R) in Israel
CSL Behring Receives National Marketing Authorization of Berinert(R) in Israel
HSMN NewsFeed - 19 Jan 2011
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
HSMN NewsFeed - 21 Oct 2010
Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
HSMN NewsFeed - 5 Oct 2010
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
HSMN NewsFeed - 26 May 2010
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
HSMN NewsFeed - 12 Apr 2010
Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer
Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer
HSMN NewsFeed - 29 Mar 2010
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
HSMN NewsFeed - 1 Mar 2010
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development
HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
HSMN NewsFeed - 8 Jan 2010
Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations
Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations
HSMN NewsFeed - 17 Dec 2009
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
HSMN NewsFeed - 7 Dec 2009
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
HSMN NewsFeed - 21 Oct 2009
NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
HSMN NewsFeed - 5 Oct 2009
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
HSMN NewsFeed - 14 Aug 2009
Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
HSMN NewsFeed - 12 Aug 2009
Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations
Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations
HSMN NewsFeed - 8 Jul 2009
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
Antares Pharma Promotes Robert F. Apple, Dr. Kaushik Dave and Dr. Peter Sadowski
HSMN NewsFeed - 8 Jul 2009
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
HSMN NewsFeed - 17 Mar 2009
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
HSMN NewsFeed - 4 Feb 2009
FDA Advisory Committee Favors Approval of DX-88 for Acute Attacks of Hereditary Angioedema
FDA Advisory Committee Favors Approval of DX-88 for Acute Attacks of Hereditary Angioedema
HSMN NewsFeed - 29 Jan 2009
Safeguard Scientifics Joins $10.4 Million Financing of Garnet Biotherapeutics
Safeguard Scientifics Joins $10.4 Million Financing of Garnet Biotherapeutics
HSMN NewsFeed - 27 Jan 2009
Oxygen Biotherapeutics, Inc. Submits Request for Designation to FDA for Oxycyte(R)-based Wound Care Product
Oxygen Biotherapeutics, Inc. Submits Request for Designation to FDA for Oxycyte(R)-based Wound Care Product
HSMN NewsFeed - 26 Jan 2009
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
HSMN NewsFeed - 13 Jan 2009
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
HSMN NewsFeed - 22 Sep 2008
Oxygen Biotherapeutics, Inc. Announces License Agreement for Its Glucose Biosensor Technology
Oxygen Biotherapeutics, Inc. Announces License Agreement for Its Glucose Biosensor Technology
HSMN NewsFeed - 12 Sep 2008
Oxygen Biotherapeutics, Inc. Names Robert F. Diegelmann to Lead New Wound Care Division
Oxygen Biotherapeutics, Inc. Names Robert F. Diegelmann to Lead New Wound Care Division
HSMN NewsFeed - 2 Sep 2008
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
HSMN NewsFeed - 25 Aug 2008
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
HSMN NewsFeed - 18 Aug 2008
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
HSMN NewsFeed - 12 Aug 2008
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
HSMN NewsFeed - 11 Aug 2008
Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
HSMN NewsFeed - 7 Aug 2008
Dyax Corp. Announces the Appointment of George Migausky as Chief Financial Officer
Dyax Corp. Announces the Appointment of George Migausky as Chief Financial Officer
HSMN NewsFeed - 23 Jul 2008
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
HSMN NewsFeed - 1 Jul 2008
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
HSMN NewsFeed - 23 Jun 2008
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
HSMN NewsFeed - 2 Jun 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
HSMN NewsFeed - 22 May 2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
HSMN NewsFeed - 24 Apr 2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
HSMN NewsFeed - 14 Mar 2008
Genentech Provides Business Update at Annual Investment Community Meeting
Genentech Provides Business Update at Annual Investment Community Meeting
HSMN NewsFeed - 13 Mar 2008
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
HSMN NewsFeed - 4 Mar 2008
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
HSMN NewsFeed - 25 Feb 2008
Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexamination Process
Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexamination Process
HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
HSMN NewsFeed - 23 Jan 2008
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
HSMN NewsFeed - 23 Jan 2008
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
HSMN NewsFeed - 10 Jan 2008
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
HSMN NewsFeed - 26 Nov 2007
CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
HSMN NewsFeed - 16 Nov 2007
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
HSMN NewsFeed - 14 Nov 2007
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
HSMN NewsFeed - 8 Nov 2007
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
HSMN NewsFeed - 31 Oct 2007
Dyax Announces the Appointment of William Pullman as Executive Vice President and Chief Development Officer
Dyax Announces the Appointment of William Pullman as Executive Vice President and Chief Development Officer
HSMN NewsFeed - 4 Oct 2007
Dr. Martin Mackay Named President of Pfizer Global Research and Development
Dr. Martin Mackay Named President of Pfizer Global Research and Development
HSMN NewsFeed - 24 Sep 2007
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 4 Sep 2007
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
HSMN NewsFeed - 27 Aug 2007
Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
HSMN NewsFeed - 9 Jul 2007
World's First Therapeutic Vaccine for Brain Cancer Commercially Available to Patients in Switzerland
World's First Therapeutic Vaccine for Brain Cancer Commercially Available to Patients in Switzerland
HSMN NewsFeed - 4 Jun 2007
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
HSMN NewsFeed - 3 Jun 2007
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
HSMN NewsFeed - 14 May 2007
Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
HSMN NewsFeed - 14 May 2007
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
HSMN NewsFeed - 4 May 2007
Xcellerex Announces Appointment of Joseph Zakrzewski as Chief Executive Officer
Xcellerex Announces Appointment of Joseph Zakrzewski as Chief Executive Officer
HSMN NewsFeed - 4 May 2007
Dyax Announces the Resignation of Thomas Beck, M.D., President and Chief Operating Officer
Dyax Announces the Resignation of Thomas Beck, M.D., President and Chief Operating Officer
HSMN NewsFeed - 26 Apr 2007
Dyax Announces the Appointment of Gustav Christensen as Executive Vice President and Chief Business Officer
Dyax Announces the Appointment of Gustav Christensen as Executive Vice President and Chief Business Officer
HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
HSMN NewsFeed - 17 Apr 2007
Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
HSMN NewsFeed - 12 Apr 2007
DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
HSMN NewsFeed - 10 Apr 2007
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
HSMN NewsFeed - 2 Apr 2007
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
HSMN NewsFeed - 13 Mar 2007
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
HSMN NewsFeed - 13 Mar 2007
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R)
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R)
HSMN NewsFeed - 1 Feb 2007
CSL Behring and Bayer Extend Agreement for Supply of Helixate(R) Recombinant Coagulation Factor
CSL Behring and Bayer Extend Agreement for Supply of Helixate(R) Recombinant Coagulation Factor
HSMN NewsFeed - 9 Jan 2007
U.S. Patent Office Allows CVBT's Patent Application for the Injection of FGF-1 Into the Human Heart
U.S. Patent Office Allows CVBT's Patent Application for the Injection of FGF-1 Into the Human Heart
HSMN NewsFeed - 2 Jan 2007
Hospitals, Healthcare Providers to Save with Premier Plasma Distribution Agreement with FFF Enterprises
Hospitals, Healthcare Providers to Save with Premier Plasma Distribution Agreement with FFF Enterprises
HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
HSMN NewsFeed - 18 Dec 2006
ZLB Behring Completes Purchase of CytoGam(R) Immunoglobulin Therapy From MedImmune
ZLB Behring Completes Purchase of CytoGam(R) Immunoglobulin Therapy From MedImmune
HSMN NewsFeed - 16 Nov 2006
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
HSMN NewsFeed - 24 Oct 2006
CardioVascular BioTherapeutics Initiates Study on the Treatment of Peripheral Artery Disease
CardioVascular BioTherapeutics Initiates Study on the Treatment of Peripheral Artery Disease
HSMN NewsFeed - 18 Oct 2006
CardioVascular BioTherapeutics Appoints Mike Norris Vice President of Business Development
CardioVascular BioTherapeutics Appoints Mike Norris Vice President of Business Development
HSMN NewsFeed - 4 Oct 2006
Genentech Announces Vice President Appointments in Commercial Operations and Manufacturing
Genentech Announces Vice President Appointments in Commercial Operations and Manufacturing
HSMN NewsFeed - 29 Sep 2006
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
HSMN NewsFeed - 29 Sep 2006
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
HSMN NewsFeed - 28 Sep 2006
INEX Updates Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
INEX Updates Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
HSMN NewsFeed - 21 Sep 2006
Shareholders of Inex Pharmaceuticals Approve Spin Out of Tekmira Pharmaceuticals Corporation
Shareholders of Inex Pharmaceuticals Approve Spin Out of Tekmira Pharmaceuticals Corporation
HSMN NewsFeed - 5 Sep 2006
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
HSMN NewsFeed - 31 Aug 2006
Dyax Announces Update Regarding Regulatory Pathway for DX-88 (ecallantide) in Hereditary Angioedema
Dyax Announces Update Regarding Regulatory Pathway for DX-88 (ecallantide) in Hereditary Angioedema
HSMN NewsFeed - 29 Aug 2006
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
HSMN NewsFeed - 22 Aug 2006
CardioVascular BioTherapeutics Co-Founder Presents Seminar on Potential New Heart Disease Treatment
CardioVascular BioTherapeutics Co-Founder Presents Seminar on Potential New Heart Disease Treatment
HSMN NewsFeed - 30 Jun 2006
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
HSMN NewsFeed - 27 Jun 2006
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
HSMN NewsFeed - 24 May 2006
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
HSMN NewsFeed - 23 May 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
HSMN NewsFeed - 11 May 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
HSMN NewsFeed - 10 Apr 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
HSMN NewsFeed - 6 Mar 2006
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
HSMN NewsFeed - 24 Feb 2006
Premier's New Plasma and Recombinant Program Helps Hospitals Acquire Products in Short Supply
Premier's New Plasma and Recombinant Program Helps Hospitals Acquire Products in Short Supply
HSMN NewsFeed - 23 Feb 2006
CVBT Discusses Advances in Drug Development Program for New Stroke Treatments
CVBT Discusses Advances in Drug Development Program for New Stroke Treatments
HSMN NewsFeed - 22 Feb 2006
Brain Cancer Patients Living Longer and Doing Better After Personalized Vaccine Therapy
Brain Cancer Patients Living Longer and Doing Better After Personalized Vaccine Therapy
HSMN NewsFeed - 13 Feb 2006
Recruitment Temporarily Suspended in an International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Recruitment Temporarily Suspended in an International Phase III Trial (AVANT) in Early-Stage Colon Cancer
HSMN NewsFeed - 23 Jan 2006
Cardium Therapeutics Announces Appointment of Chief Medical Officer to Lead Generx(TM) Development Program
Cardium Therapeutics Announces Appointment of Chief Medical Officer to Lead Generx(TM) Development Program
Additional items found! 227

Members Archive contains
227 additional stories matching:
BioTherapeutics
(Password required)
BioTherapeutics
(Password required)